Altamira Therapeutics Ltd. (CYTOF): Shareholders' Equity

Annual figures by period end, from SEC filings.

Not updated since 2020-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

16.77M CHF
As of 2020-12-31
2019-12-31: 6.04M CHF2020-12-31: 16.77M CHF16.77M CHF
2019-12-31 Shareholders' Equity (CHF) 2020-12-31
Period endedShareholders' EquityChange YoYSource filing
2020-12-3116.77M CHF+177.8%2021-03-31, Balance as of period end
2019-12-316.04M CHFn/a2021-03-31, Balance as of period end